Nifty
Sensex
:
:
11521.05
38386.75
-11.35 (-0.10%)
23.28 (0.06%)

Pharmaceuticals & Drugs

Rating :
58/99

BSE: 506197 | NSE: BLISSGVS

166.95
-1.00 (-0.60%)
20-Mar-2019 | 3:56PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  168.90
  •  169.90
  •  166.05
  •  167.95
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  617683
  •  1031.22
  •  215.65
  •  125.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 1,727.71
  • 18.92
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 1,756.80
  • 0.60%
  • 2.73

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 50.47%
  • 12.15%
  • 12.66%
  • FII
  • DII
  • Others
  • 0.01%
  • 0.00%
  • 24.71%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 8.40
  • 18.77
  • 14.21

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 8.48
  • 22.58
  • 4.83

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 4.29
  • 7.48
  • -10.68

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 15.85
  • 19.68
  • 19.38

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.65
  • 3.37
  • 3.28

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 7.17
  • 9.30
  • 8.24

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 18
Dec 17
Var%
Sep 18
Sep 17
Var%
Jun 18
Jun 17
Var%
Mar 18
Mar 17
Var%
Net Sales
220.44
195.92
12.52%
228.43
226.55
0.83%
205.33
225.57
-8.97%
167.10
258.38
-35.33%
Expenses
176.90
147.86
19.64%
186.90
179.09
4.36%
164.70
161.48
1.99%
129.56
182.28
-28.92%
EBITDA
43.54
48.06
-9.40%
41.53
47.46
-12.49%
40.64
64.09
-36.59%
37.53
76.10
-50.68%
EBIDTM
19.75%
24.53%
18.18%
20.95%
19.79%
28.41%
22.46%
29.45%
Other Income
-3.90
2.34
-
24.88
15.16
64.12%
13.87
3.50
296.29%
5.54
-6.84
-
Interest
0.96
4.72
-79.66%
1.27
6.15
-79.35%
1.26
6.48
-80.56%
5.45
7.69
-29.13%
Depreciation
2.19
6.56
-66.62%
2.34
4.86
-51.85%
2.21
5.09
-56.58%
4.87
1.17
316.24%
PBT
36.48
39.12
-6.75%
62.80
51.60
21.71%
51.04
56.02
-8.89%
-1.44
60.40
-
Tax
9.25
13.13
-29.55%
21.13
12.10
74.63%
12.06
19.12
-36.92%
12.28
17.80
-31.01%
PAT
27.23
25.98
4.81%
41.66
39.50
5.47%
38.98
36.90
5.64%
-13.72
42.60
-
PATM
12.35%
13.26%
18.24%
17.43%
18.98%
16.36%
-8.21%
16.49%
EPS
2.50
1.74
43.68%
4.02
3.29
22.19%
3.72
2.05
81.46%
-1.39
3.21
-

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Net Sales
821.30
814.64
798.44
546.89
407.13
344.64
396.63
267.07
218.84
Net Sales Growth
-9.39%
2.03%
46.00%
34.33%
18.13%
-13.11%
48.51%
22.04%
 
Cost Of Goods Sold
515.46
391.13
358.93
237.18
152.77
132.01
167.90
145.83
112.20
Gross Profit
305.84
423.52
439.51
309.72
254.37
212.63
228.72
121.24
106.65
GP Margin
37.24%
51.99%
55.05%
56.63%
62.48%
61.70%
57.67%
45.40%
48.73%
Total Expenditure
658.06
617.50
595.70
391.17
303.70
273.42
285.47
195.73
160.11
Power & Fuel Cost
-
5.49
5.58
4.72
4.36
2.93
2.18
1.02
0.54
% Of Sales
-
0.67%
0.70%
0.86%
1.07%
0.85%
0.55%
0.38%
0.25%
Employee Cost
-
69.23
61.35
33.74
29.43
23.46
15.08
6.26
3.53
% Of Sales
-
8.50%
7.68%
6.17%
7.23%
6.81%
3.80%
2.34%
1.61%
Manufacturing Exp.
-
4.88
5.39
25.65
29.98
41.44
37.17
12.66
15.88
% Of Sales
-
0.60%
0.68%
4.69%
7.36%
12.02%
9.37%
4.74%
7.26%
General & Admin Exp.
-
40.12
36.36
24.68
17.07
15.16
14.63
7.36
5.21
% Of Sales
-
4.92%
4.55%
4.51%
4.19%
4.40%
3.69%
2.76%
2.38%
Selling & Distn. Exp.
-
62.00
92.46
42.51
47.05
35.12
40.26
21.13
15.75
% Of Sales
-
7.61%
11.58%
7.77%
11.56%
10.19%
10.15%
7.91%
7.20%
Miscellaneous Exp.
-
44.67
35.63
22.71
23.03
23.30
8.25
1.47
7.01
% Of Sales
-
5.48%
4.46%
4.15%
5.66%
6.76%
2.08%
0.55%
3.20%
EBITDA
163.24
197.14
202.74
155.72
103.43
71.22
111.16
71.34
58.73
EBITDA Margin
19.88%
24.20%
25.39%
28.47%
25.40%
20.67%
28.03%
26.71%
26.84%
Other Income
40.39
26.54
12.51
24.35
20.29
28.00
14.07
15.75
1.87
Interest
8.94
22.80
19.69
18.61
16.41
17.98
9.72
4.03
2.15
Depreciation
11.61
21.38
20.14
13.26
11.30
10.68
6.03
3.65
5.47
PBT
148.88
179.49
175.40
148.19
96.02
70.56
109.48
79.42
52.98
Tax
54.72
56.63
62.72
48.05
34.63
29.53
49.90
26.88
12.35
Tax Rate
36.75%
38.98%
35.76%
32.42%
36.07%
41.85%
45.58%
33.85%
23.31%
PAT
94.15
58.78
82.04
82.49
59.91
40.99
57.72
52.54
40.63
PAT before Minority Interest
91.29
88.66
112.68
100.15
61.39
41.03
59.58
52.54
40.63
Minority Interest
-2.86
-29.88
-30.64
-17.66
-1.48
-0.04
-1.86
0.00
0.00
PAT Margin
11.46%
7.22%
10.28%
15.08%
14.72%
11.89%
14.55%
19.67%
18.57%
PAT Growth
-35.06%
-28.35%
-0.55%
37.69%
46.16%
-28.98%
9.86%
29.31%
 
Unadjusted EPS
8.85
5.70
7.95
8.00
5.81
3.97
5.60
5.09
3.94

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Shareholder's Funds
536.24
486.62
412.62
337.08
286.88
258.01
210.66
166.62
Share Capital
10.31
10.31
10.31
10.31
10.31
10.31
10.31
10.31
Total Reserves
525.92
476.31
402.31
326.77
276.57
247.69
200.35
156.31
Non-Current Liabilities
12.92
32.81
49.55
67.52
95.65
96.92
39.34
3.86
Secured Loans
5.92
25.58
29.62
55.03
78.80
89.97
37.63
3.65
Unsecured Loans
0.00
0.00
8.62
2.23
8.79
1.33
0.00
0.00
Long Term Provisions
1.91
2.05
1.81
1.40
1.10
0.74
0.51
0.58
Current Liabilities
299.40
437.09
378.97
242.68
307.66
202.19
59.74
42.64
Trade Payables
58.43
98.25
108.49
80.33
82.35
118.15
40.15
31.40
Other Current Liabilities
124.46
99.93
52.76
70.30
42.12
24.45
6.10
4.35
Short Term Borrowings
105.66
187.47
62.12
61.04
57.05
45.16
5.90
3.29
Short Term Provisions
10.85
51.45
155.60
31.00
126.14
14.44
7.58
3.61
Total Liabilities
860.04
1,022.90
874.24
662.17
700.35
570.92
309.74
213.12
Net Block
136.48
303.86
225.25
234.38
213.31
168.23
40.03
19.93
Gross Block
157.47
326.83
300.74
293.82
262.45
205.92
64.41
40.84
Accumulated Depreciation
20.99
22.97
75.48
59.44
49.14
37.69
24.38
20.91
Non Current Assets
172.61
456.97
291.23
244.66
229.67
219.61
100.21
56.57
Capital Work in Progress
0.47
4.03
9.10
0.00
4.33
0.65
6.91
7.55
Non Current Investment
6.30
1.05
0.11
0.01
0.01
0.01
0.00
0.00
Long Term Loans & Adv.
19.31
11.45
56.77
10.27
12.02
50.72
53.28
29.09
Other Non Current Assets
10.06
136.58
0.00
0.00
0.00
0.00
0.00
0.00
Current Assets
687.43
565.93
583.00
417.08
469.26
348.89
209.54
156.55
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.80
0.00
Inventories
59.03
49.30
38.67
33.70
32.53
32.52
12.68
11.61
Sundry Debtors
298.48
254.45
300.93
247.47
215.03
244.64
128.59
119.61
Cash & Bank
88.86
150.50
78.18
57.29
80.37
50.35
58.01
17.98
Other Current Assets
241.06
33.24
15.30
17.93
141.34
21.37
9.46
7.35
Short Term Loans & Adv.
129.27
78.44
149.92
60.69
130.30
8.92
5.09
2.62
Net Current Assets
388.03
128.84
204.03
174.40
161.60
146.70
149.80
113.91
Total Assets
860.04
1,022.90
874.23
662.17
700.35
570.91
309.75
213.12

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Cash From Operating Activity
17.64
289.47
112.95
48.94
41.15
6.50
35.46
0.00
PBT
179.49
175.40
148.19
96.02
70.56
109.48
79.42
0.00
Adjustment
17.55
36.24
18.18
22.48
24.11
9.71
4.76
0.00
Changes in Working Capital
-140.80
113.48
-8.33
-60.94
-19.30
-73.94
-37.83
0.00
Cash after chg. in Working capital
56.24
325.13
158.05
57.56
75.36
45.25
46.35
0.00
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-38.61
-35.66
-45.10
-8.63
-34.21
-38.75
-10.89
0.00
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
56.14
-231.25
-49.84
-38.98
-10.90
-124.05
-21.91
0.00
Net Fixed Assets
-1.04
42.08
-5.32
-28.78
-12.86
-12.91
-16.65
Net Investments
2.37
-0.95
-1.36
0.00
-0.01
-18.19
-1.03
Others
54.81
-272.38
-43.16
-10.20
1.97
-92.95
-4.23
Cash from Financing Activity
-75.98
-10.13
-40.25
-43.26
-8.47
109.89
26.48
0.00
Net Cash Inflow / Outflow
-2.19
48.09
22.85
-33.31
21.77
-7.66
40.02
0.00
Opening Cash & Equivalents
0.00
0.00
5.09
49.57
27.79
58.01
17.98
0.00
Closing Cash & Equivalent
42.86
47.41
27.60
16.26
49.57
50.35
58.01
0.00

Financial Ratios

Standalone /

Consolidated
Description
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Book Value (Rs.)
51.99
47.18
40.00
32.64
27.67
24.78
20.42
16.15
ROA
9.42%
11.88%
13.04%
9.01%
6.46%
13.53%
20.09%
19.06%
ROE
17.34%
25.06%
26.73%
19.74%
15.17%
25.56%
27.85%
24.38%
ROCE
24.61%
31.06%
32.07%
23.57%
20.56%
36.18%
38.76%
31.53%
Fixed Asset Turnover
3.37
2.56
1.85
1.47
1.48
2.95
5.09
5.37
Receivable days
123.80
126.33
182.13
206.07
241.81
171.03
169.17
199.09
Inventory Days
24.25
20.01
24.04
29.51
34.22
20.71
16.56
19.33
Payable days
51.75
67.63
95.25
108.77
148.76
105.12
67.61
73.84
Cash Conversion Cycle
96.30
78.70
110.92
126.81
127.26
86.63
118.11
144.57
Total Debt/Equity
0.22
0.46
0.32
0.47
0.60
0.58
0.21
0.05
Interest Cover
7.37
9.91
8.96
6.85
4.92
12.27
20.70
25.67

News Update:


  • Bliss GVS Pharma - Quarterly Results
    29th Jan 2019, 21:00 PM

    Read More
  • Arian Investment hikes stake in Bliss GVS Pharma
    28th Dec 2018, 11:53 AM

    Arian Investment’s holding in the company now stands at 9.22%

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.